Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy

JACC: Heart Failure

Volumn 2, Issue 3, 2014, Pages 230-237

  Chatterjee, Neal A ^a   Upadhyay, Gaurav A ^a   Singal, Gaurav ^a   Parks, Kimberly A ^a   Dec, G William ^a   Singh, Jagmeet P ^a   Lewis, Gregory D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiac resynchronization therapy; Pulmonary hypertension; Right ventricle

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART TRANSPLANTATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY TRACT PARAMETERS; RIGHT VENTRICULAR DILATION; TRANSPULMONARY GRADIENT; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE; ADVERSE OUTCOME; CAUSE OF DEATH; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; RISK ASSESSMENT; VASODILATATION; CAPILLARY; COHORT ANALYSIS; COMPLICATION; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; RECURRENT DISEASE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; CAPILLARIES; CARDIAC CATHETERIZATION; CARDIAC RESYNCHRONIZATION THERAPY; COHORT STUDIES; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; RECURRENCE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84901688990     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.02.004     Document Type: Article

References (39)

1. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150.
2. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
3. Tang A.S., Wells G.A., Talajic M., et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010, 363:2385-2395.
4. Moss A.J., Hall W.J., Cannom D.S., et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009, 361:1329-1338.
5. Simonneau G., Robbins I.M., Beghetti M., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43-S54.
6. Guazzi M., Borlaug B.A. Pulmonary hypertension due to left heart disease. Circulation 2012, 126:975-990.
7. Schwartzenberg S., Redfield M.M., From A.M., Sorajja P., Nishimura R.A., Borlaug B.A. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol 2012, 59:442-451.
8. Abramson S.V., Burke J.F., Kelly J.J., et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992, 116:888-895.
9. Costard-Jackle A., Fowler M.B. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992, 19:48-54.
10. Bursi F., McNallan S.M., Redfield M.M., et al. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol 2012, 59:222-231.
11. Mancini D., Katz S., Donchez L., Aaronson K. Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure. Circulation 1996, 94:2492-2496.
12. Cappola T.P., Felker G.M., Kao W.H., Hare J.M., Baughman K.L., Kasper E.K. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 2002, 105:1663-1668.
13. Chatterjee N.A., Lewis G.D. What is the prognostic significance of pulmonary hypertension in heart failure?. Circ Heart Fail 2011, 4:541-545.
14. Aronson D., Eitan A., Dragu R., Burger A.J. Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure. Circ Heart Fail 2011, 4:644-650.
15. Khush K.K., Tasissa G., Butler J., McGlothlin D., De Marco T. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J 2009, 157:1026-1034.
16. Stern J., Heist E.K., Murray L., et al. Elevated estimated pulmonary artery systolic pressure is associated with an adverse clinical outcome in patients receiving cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007, 30:603-607.
17. Tedrow U.B., Kramer D.B., Stevenson L.W., et al. Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy. Am J Cardiol 2006, 97:1737-1740.
18. Altman R.K., Parks K.A., Schlett C.L., et al. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J 2012, 33:2181-2188.
19. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
20. Rudski L.G., Lai W.W., Afilalo J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010, 23:685-713. quiz 786-8.
21. Butler J., Chomsky D.B., Wilson J.R. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 1999, 34:1802-1806.
22. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001, 37:183-188.
23. Shalaby A., Voigt A., El-Saed A., Saba S. Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure. Am J Cardiol 2008, 101:238-241.
24. Lewis G.D., Murphy R.M., Shah R.V., et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 2011, 4:276-285.
25. Lewis G.D., Shah R., Shahzad K., et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007, 116:1555-1562.
26. Capomolla S., Febo O., Guazzotti G., et al. Invasive and non-invasive determinants of pulmonary hypertension in patients with chronic heart failure. J Heart Lung Transplant 2000, 19:426-438.
27. Enriquez-Sarano M., Rossi A., Seward J.B., Bailey K.R., Tajik A.J. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 1997, 29:153-159.
28. Tribouilloy C.M., Enriquez-Sarano M., Rossi A., Tajik A.J., Seward J.B. Determinants of the pulmonary artery pressure rise in left ventricular dysfunction. Cardiologia 1997, 42:1051-1058.
29. Sipahi I., Carrigan T.P., Rowland D.Y., Stambler B.S., Fang J.C. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 2011, 171:1454-1462.
30. Lin G., Gersh B.J., Greene E.L., Redfield M.M., Hayes D.L., Brady P.A. Renal function and mortality following cardiac resynchronization therapy. Eur Heart J 2011, 32:184-190.
31. Lechat P., Packer M., Chalon S., Cucherat M., Arab T., Boissel J.P. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998, 98:1184-1191.
32. Sun J.P., James K.B., Yang X.S., et al. Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities. Am J Cardiol 1997, 80:1583-1587.
33. Atherton J.J., Moore T.D., Lele S.S., et al. Diastolic ventricular interaction in chronic heart failure. Lancet 1997, 349:1720-1724.
34. Dong S.J., Crawley A.P., MacGregor J.H., et al. Regional left ventricular systolic function in relation to the cavity geometry in patients with chronic right ventricular pressure overload. A three-dimensional tagged magnetic resonance imaging study. Circulation 1995, 91:2359-2370.
35. Marcus J.T., Gan C.T., Zwanenburg J.J., et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 2008, 51:750-757.
36. Dohi K., Onishi K., Gorcsan J., et al. Role of radial strain and displacement imaging to quantify wall motion dyssynchrony in patients with left ventricular mechanical dyssynchrony and chronic right ventricular pressure overload. Am J Cardiol 2008, 101:1206-1212.
37. Louie E.K., Lin S.S., Reynertson S.I., Brundage B.H., Levitsky S., Rich S. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation 1995, 92:819-824.
38. Kandala J., Altman R.K., Park M.Y., Singh J.P. Clinical, laboratory, and pacing predictors of CRT response. J Cardiovasc Transl Res 2012, 5:196-212.
39. Pons J., Leblanc M.H., Bernier M., et al. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation. J Heart Lung Transplant 2012, 31:1281-1287.